Global Renal Denervation Market Report: 2012 Edition - New Report by Koncept Analytics

Sept. 4, 2012 - PRLog -- Affecting the lives of millions of people across the globe, hypertension is a chronic medical condition which substantially raises the risk of cardiac malfunction, kidney diseases and insulin resistance. However if the condition is tamed by managing the blood pressure, it suppresses the risk of occurrence of adverse events significantly. But, if it is left untreated, increases the risk of mortality from ischemic heart disease and stroke two folds.

Renal artery denervation (RDN), is a novel therapeutic paradigm meant for treating the resistant hypertension. Basically RDN is a catheter-based therapy which employs either radiofrequency or ultrasound energy for tampering the renal arteries sympathetic nerves whose hyperactivity causes treatment-resistant hypertension.

This report includes following sub-sections:-

1. Hypertension

1.1 Overview

1.2 Global Hypertension Market

1.3 The US Hypertension Market

1.4 European Hypertension Market

2. Renal Denervation

2.1 Overview

2.2 Renal Denervation Market

3. Renal Denervation - Market Dynamics

3.1 Key Trends

3.2 Growth Drivers

3.3 Challenges

4. Renal Denervation - Competitive Landscape

5. Company Profiles

5.1 Medtronic

5.2 St. Jude Medical

5.3 Boston Scientific

5.4 Covidien

6. RDN Market Outlook

Global Market
Europe
United States
Rest of World

List of Charts

BP Pattern across various Stages of Hypertension
Global Interventional Hypertension Procedures (2011-2015E)
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
RDN Device Comparison – 30-Day BP Change
Worldwide RDN Procedure Share by Region (2011)
Worldwide RDN Revenue Share by Region (2011)
Rising Global Adult Population (2007-2012E)
World Gross National Income (2005-2010)
Medtronic’s Revenue Share by Business Segments (2012)
Medtronic’s Revenue and Net Earnings Analysis (2009-2012)
St. Jude Medical’s Revenue Share by Business Segments (2011)
St. Jude Medical’s Revenue and Net Earnings Analysis (2007-2011)
Boston Scientific’s Revenue Share by Business Segments (2011)
Boston Scientific’s Revenue and Net Income Analysis (2007-2011)
Covidien’s Revenue Share by Business Segments (2011)
Covidien’s Revenues and Net Income Analysis (2007-2011)
Worldwide RDN Procedure Share by Geography (2012E and 2020E)
Worldwide RDN Revenue Share by Geography (2012E and 2020E)
Global RDN Market Growth (2011-2015E)

List of Tables

Classes of Essential Hypertension
Global Interventional Hypertension Market Model
Patients Taking = 5 Hypertension Medications (2010)
U.S. Interventional Hypertension Unit Build (2010-2015E)
Developed Europe Interventional Hypertension Unit Build
Interventional Hypertension Treatment Products in Development
Global Renal Denervation Market (2011)
European Renal Denervation Market (2011)
US Renal Denervation Market (2011)
Rest of the World Renal Denervation Market (2011)
Clinical Trials for Competitive Technologies
Renal Denervation Programs
Renal Denervation Technologies
Renal Denervation Competitive Technologies Under Development
Global RDN Procedures and Revenue Forecast (2012E-2020E)
Europe RDN Procedures and Revenue Forecast (2012E-2020E)
The US RDN Procedures and Revenue Forecast (2012E-2020E)
Japan RDN Procedures and Revenue Forecast (2014E-2020E)
Rest of the World RDN Procedures and Revenue Forecast (2012E-2020E)



For further details,kindly visit http://www.konceptanalytics.com/reportDetail.aspx?reportI...